Dyne Therapeutics, Inc. (DYN) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Dyne Therapeutics, Inc. (DYN).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $11.36

Daily Change: -$0.23 / 2.02%

Daily Range: $11.05 - $11.92

Market Cap: $1,648,835,200

Daily Volume: 3,613,407

Performance Metrics

1 Week: 13.60%

1 Month: 26.01%

3 Months: 19.04%

6 Months: -28.64%

1 Year: -72.85%

YTD: -52.50%

Company Details

Employees: 191

Sector: Health technology

Industry: Biotechnology

Country:

Details

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Selected stocks

New Mountain Finance Corporation (NMFC)

RiverNorth Opportunities Fund, Inc. (RIV)

Dow Inc. (DOW)